BioSpace News Archive

Business

Brightree Announces Enhanced Pharmacy Suite

Home infusion therapy providers and HME pharmacies benefit from feature-rich functionality within a single software solution for all clinical, billing and reporting needs

March 7, 2019
·
3 min read
Business

ArisGlobal Launches LifeSphere Publishing as Key Component of LifeSphere Regulatory Cloud Platform

Regulatory teams benefit from a streamlined, end-to-end publishing process

March 7, 2019
·
2 min read
Business

ArisGlobal Launches Enterprise-Level Document Management Platform

LifeSphere® EasyDocs enables the life sciences industry to eliminate multiple siloed applications and reduce integration complexities while unifying document management

March 7, 2019
·
3 min read
Business

Akili and Shionogi Announce Strategic Partnership to Develop and Commercialize Digital Therapeutics in Key Asian Markets

Akili to Create First-of-its-kind International Digital Medicine Development and Commercial Platform

March 7, 2019
·
7 min read
Policy

MCRA Assists with Premarket Approval of the M6-C Artificial Cervical Disc

- 1st Spine PMA Approved by the FDA in More than Three Years

March 7, 2019
·
2 min read
Deals

Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer

Eli Lilly and Company (NYSE: LLY) today announced the final exchange ratio for its previously-announced offer for shareholders to exchange their shares of Lilly common stock for shares of Elanco Animal Health Incorporated (NYSE: ELAN) owned by Lilly.

March 7, 2019
·
5 min read
Business

Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors

Proteostasis Therapeutics, Inc. today announced that David Arkowitz has been appointed to the Company’s Board of Directors. Mr. Arkowitz is the Chief Financial Officer (CFO) and Treasurer of Flexion Therapeutics, a publicly traded, commercial stage biotechnology company.

March 7, 2019
·
4 min read
Deals

SOM Biotech Closes a Financing Round of 7M Euros

SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network.

March 7, 2019
·
3 min read
Policy

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s steps on naming of biological medicines to balance competition and safety for patients receiving these products

We’re at a critical point for the future of biosimilars in the U.S. Millions of American patients stand to benefit from increased utilization of these lower-cost, high-quality products.

March 7, 2019
·
10 min read
Business

Neonode Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results

Neonode Inc., the Optical Interactive Sensing Technology Company, reported financial results for the fourth quarter and year ended December 31, 2018.

March 7, 2019
·
4 min read